(Download XLS:)  |
|
|
Notes |
2010 |
2009 | ||
|---|---|---|---|---|---|
| |||||
|
Cash flows from operating activities |
|
|
| ||
|
|
|
|
| ||
|
Profit for the year |
|
820 |
844 | ||
|
|
|
|
| ||
|
Adjustments for non-cash movements in net profit for the year |
|
|
| ||
|
Realised and unrealised gains on financial investments and investment properties |
|
(23,673) |
(29,180) | ||
|
Investment income |
|
(8,787) |
(8,813) | ||
|
Interest expense |
|
168 |
179 | ||
|
Income tax expense |
|
487 |
395 | ||
|
Other adjustments |
|
59 |
104 | ||
|
|
|
|
| ||
|
Net (increase)/decrease in operational assets |
|
|
| ||
|
Investments held for trading or designated as fair value through profit or loss |
|
(2,958) |
(5,822) | ||
|
Investments designated as available-for-sale |
|
(39) |
(61) | ||
|
Other assets |
|
(479) |
477 | ||
|
|
|
|
| ||
|
Net increase/(decrease) in operational liabilities |
|
|
| ||
|
Insurance contracts |
|
2,746 |
3,143 | ||
|
Transfer to unallocated divisible surplus |
|
186 |
368 | ||
|
Investment contracts |
|
20,702 |
29,337 | ||
|
Value of in-force non-participating contracts |
|
(10) |
(196) | ||
|
Other liabilities |
|
4,968 |
1,121 | ||
|
Cash used in operations |
|
(5,810) |
(8,104) | ||
|
Interest paid |
|
(167) |
(160) | ||
|
Interest received |
|
5,030 |
5,074 | ||
|
Income tax (paid)/received |
|
(164) |
52 | ||
|
Dividends received |
|
3,818 |
3,896 | ||
|
Net cash flows from operating activities |
|
2,707 |
758 | ||
|
|
|
|
| ||
|
Cash flows from investing activities |
|
|
| ||
|
Net acquisition of plant and equipment |
|
(17) |
(7) | ||
|
Acquisitions (net of cash acquired)1 |
(44) |
– | |||
|
Capital injections into associates and joint ventures |
(8) |
(36) | |||
|
Net cash flows from investing activities |
|
(69) |
(43) | ||
|
|
|
|
| ||
|
Cash flows from financing activities |
|
|
| ||
|
Dividend distributions to ordinary equity holders of the Company during the year |
|
(238) |
(185) | ||
|
Proceeds from issue of ordinary share capital |
|
2 |
– | ||
|
Purchase of employee scheme shares |
|
(11) |
(2) | ||
|
Proceeds from borrowings |
|
750 |
2,124 | ||
|
Repayment of borrowings |
|
(758) |
(2,629) | ||
|
Net cash flows from financing activities |
|
(255) |
(692) | ||
|
|
|
|
| ||
|
Net increase in cash and cash equivalents |
|
2,383 |
23 | ||
|
Exchange gains/(losses) on cash and cash equivalents |
|
3 |
(61) | ||
|
Cash and cash equivalents at 1 January |
|
10,650 |
10,688 | ||
|
Cash and cash equivalents at 31 December |
13,036 |
10,650 | |||
The Group’s consolidated cash flow statement includes all cash and cash equivalent flows, including those relating to the UK long term fund policyholders.
